Live data · NADAC + Part D CY24 · reviewed daily

Omeprazole and Sodium Bicarbonate (Konvomep)

Proton Pump Inhibitor class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2004-06-15
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.562/unit
12 NDCs benchmarked, lowest of all strengths.
Average NADAC
$4.57
Across all dosage forms in distribution.
Highest NADAC
$8.11
Wide spread — brand-strength NDCs still in market.
Plans with PA
4 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Omeprazole and Sodium Bicarbonate used for?

Omeprazole and Sodium Bicarbonate is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Is there a generic for Omeprazole and Sodium Bicarbonate?

No. Omeprazole and Sodium Bicarbonate is brand-only with no generic equivalents currently in market.

How much does my plan pay for Omeprazole and Sodium Bicarbonate?

Across 329 Part D plans, Omeprazole and Sodium Bicarbonate averages $4.57/unit (NADAC). Lowest available: $0.562/unit. Highest in distribution: $8.11/unit.

Is Omeprazole and Sodium Bicarbonate on the FDA shortage list?

No. Omeprazole and Sodium Bicarbonate is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (12 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.